wPerm (version 1.0.1)

bmi:

Denosumab and Osteoporosis

Description

Body mass index for postmenopausal women with osteoporosis given six different treatments of Denosumab.

Usage

data("bmi")

Format

A data frame with 236 observations on the following 2 variables.

BMI

a numeric vector

TREATMENT

a factor with levels 100-mg 14-mg 210-mg 60-mg Placebo

Source

McClung, M., et al. (2006) Denosumab in Postmenopausal Women with Low Bone Mineral Density. New England Journal of Medicine, 354, pp. 821-831.

Details

A clinical study was conducted to see whether an antibody called denosumab is effective in treatment of osteoporosis of postmenopausal women. In the article cited below, researchers reported on a study where women with osteoporosis were randomly assigned into groups that received either a placebo, or a six-month regimen of Denosumab at doses of 14 mg, 60 mg, 100 mg, or 210 mg. The bmi dataset provides data on the body-mass indexes (BMI) of the women in each treatment group.

Examples

data(bmi)
str(bmi)
attach(bmi)
plot(BMI ~ TREATMENT)
detach(bmi)